T. Rowe Price Investment Management, Inc. Immatics N.V. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immatics N.V. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 7,433,707 shares of IMTX stock, worth $69.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,433,707
Previous 6,304,672
17.91%
Holding current value
$69.5 Million
Previous $66.3 Million
30.36%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding IMTX
# of Institutions
100Shares Held
76.8MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$93.5 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$89.2 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$75.6 Million2.72% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$60.2 Million1.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$34 Million0.01% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $713M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...